Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

被引：12

作者：

Collier, Anderson B., III ^{[1
]}

Krailo, Mark D. ^{[2
]}

Dang, Ha M. ^{[2
]}

DuBois, Steven G. ^{[3
,4
]}

Hawkins, Douglas S. ^{[5
]}

Bernstein, Mark L. ^{[6
]}

Bomgaars, Lisa R. ^{[7
]}

Reed, Damon R. ^{[8
,9
,10
]}

Gorlick, Richard G. ^{[11
]}

Janeway, Katherine A. ^{[3
,4
]}

机构：

[1] Univ Mississippi, Dept Pediat, Med Ctr, 2500 North Sate St, Jackson, MS 38219 USA

[2] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA

[3] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA

[4] Harvard Med Sch, Boston, MA 02115 USA

[5] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA

[6] Dalhousie Univ, IWK Hlth Ctr, Port Williams, NS, Canada

[7] Baylor Coll Med, Dept Pediat, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA

[8] Johns Hopkins All Childrens Hosp, Canc Ctr, St Petersburg, FL USA

[9] Johns Hopkins All Childrens Hosp, Blood Disorders Inst, St Petersburg, FL USA

[10] H Lee Moffitt Canc Ctr & Res Inst, Dept Individualized Canc Management, Tampa, FL USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

PEDIATRIC BLOOD & CANCER | 2021年 / 68卷 / 12期

关键词：

event-free survival; Ewing sarcoma; objective response; outcome; phase; 2; trials; relapsed; REFRACTORY SOLID TUMORS; II TRIAL; CHEMOTHERAPY; CRITERIA;

D O I：

10.1002/pbc.29333

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SevenChildren's Oncology Group phase 2 trials for patients with relapsed/progressive solid tumors were analyzed to estimate the event-free survival (EFS) for relapsed/progressive Ewing sarcoma. One hundred twenty-eight Ewing sarcoma patients were enrolled and 124 events occurred. The 6-month EFS was 12.7%, demonstrating the poor outcome of these patients. Only docetaxel achieved its protocol-specified radiographic response rate for activity; however, the EFS for docetaxel was similar to other agents, indicating that a higher radiographic response rate may not translate into superior disease control. This EFS benchmark could be utilized as an additional endpoint in trials for recurrent Ewing sarcoma.

引用

页数：5

共 50 条

[1] Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group
Oberoi, Sapna
Qumseya, Amira
Xue, Wei
Venkatramani, Rajkumar
Weiss, Aaron R.
CANCER, 2024, : 2493 - 2502
[2] Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group
DuBois, Steven G.
Krailo, Mark D.
Lessnick, Stephen L.
Smith, Richard
Chen, Zhengjia
Marina, Neyssa
Grier, Holcombe E.
Stegmaier, Kimberly
PEDIATRIC BLOOD & CANCER, 2009, 52 (03) : 324 - 327
[3] A decade in banking Ewing sarcoma: a report from the Children's Oncology Group
Borinstein, Scott C.
Beeler, Natalie
Block, John J.
Gorlick, Richard
Grohar, Patrick
Jedlicka, Paul
Krailo, Mark
Morris, Carol
Phillips, Sharon
Siegal, Gene P.
Lawlor, Elizabeth R.
Lessnick, Stephen L.
FRONTIERS IN ONCOLOGY, 2013, 3
[4] Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group
Najat C. Daw
Nadia N. Laack
Elizabeth J. McIlvaine
Mark Krailo
Richard B. Womer
Linda Granowetter
Holcombe E. Grier
Neyssa M. Marina
Mark L. Bernstein
Mark C. Gebhardt
Karen J. Marcus
Shailesh M. Advani
John H. Healey
George D. Letson
Richard G. Gorlick
R. Lor Randall
Annals of Surgical Oncology, 2016, 23 : 3541 - 3547
[5] Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group
Daw, Najat C.
Laack, Nadia N.
McIlvaine, Elizabeth J.
Krailo, Mark
Womer, Richard B.
Granowetter, Linda
Grier, Holcombe E.
Marina, Neyssa M.
Bernstein, Mark L.
Gebhardt, Mark C.
Marcus, Karen J.
Advani, Shailesh M.
Healey, John H.
Letson, George D.
Gorlick, Richard G.
Randall, R. Lor
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3541 - 3547
[6] Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma A Report From the Children's Oncology Group
DuBois, Steven G.
Krailo, Mark D.
Buxton, Allen
Lessnick, Stephen L.
Teot, Lisa A.
Rakheja, Dinesh
Crompton, Brian D.
Janeway, Katherine A.
Gorlick, Richard G.
Glade-Bender, Julia
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (12) : 1564 - 1568
[7] Outcome of patients with recurrent/refractory osteosarcoma enrolled in three recent phase II trials: A report from the Children's Oncology Group.
Rao, Seema
Han, Ruxu
Krailo, Mark D.
Buxton, Allen
Hingorani, Pooja
Chou, Alexander J.
Gorlick, Richard Greg
Reed, Damon R.
Janeway, Katherine A.
Kopp, Lisa M.
Weigel, Brenda
Isakoff, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8] Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward
Lagmay, Joanne P.
Krailo, Mark D.
Dang, Ha
Kim, AeRang
Hawkins, Douglas S.
Beaty, Orren, III
Widemann, Brigitte C.
Zwerdling, Theodore
Bomgaars, Lisa
Langevin, Anne-Marie
Grier, Holcombe E.
Weigel, Brenda
Blaney, Susan M.
Gorlick, Richard
Janeway, Katherine A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3031 - +
[9] Clinical Outcome in Patients With Metastatic Ewing's Sarcoma Family of Tumors: A Retrospective Report From the Japan Ewing Sarcoma Study Group
Umeda, K.
Miyamura, T.
Yamada, K.
Sano, H.
Hosono, A.
Sumi, M.
Ohkita, H.
Kamio, T.
Maeda, N.
Fujisaki, H.
Jyoko, R.
Watanabe, A.
Hosoya, Y.
Hasegawa, D.
Takenaka, S.
Nakagawa, S.
Chin, M.
Ozaki, T.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S146 - S147
[10] Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group
Cash, Thomas
McIlvaine, Elizabeth
Krailo, Mark D.
Lessnick, Stephen L.
Lawlor, Elizabeth R.
Laack, Nadia
Sorger, Joel
Marina, Neyssa
Grier, Holcombe E.
Granowetter, Linda
Womer, Richard B.
DuBois, Steven G.
PEDIATRIC BLOOD & CANCER, 2016, 63 (10) : 1771 - 1779

← 1 2 3 4 5 →